[Translation] A randomized, open-label, single-dose, two-formulation, crossover design formal bioequivalence trial of sildenafil citrate oral suspension in Chinese healthy subjects
主要目的:以上海礼易医药科技有限公司申报的枸橼酸西地那非口服混悬液为受试制剂;并以辉瑞制药有限公司的枸橼酸西地那非片为参比制剂,进行人体相对生物利用度和生物等效性评价。
[Translation] Main purpose: To evaluate the relative bioavailability and bioequivalence of sildenafil citrate oral suspension applied by Shanghai Liyi Pharmaceutical Technology Co., Ltd. as the test preparation and sildenafil citrate tablets of Pfizer Pharmaceuticals Co., Ltd. as the reference preparation.